Outcomes in the Treatment of Thrombotic Thrombocytopenic Purpura With Splenectomy: A Retrospective Cohort Study
Evaluation of QT Dispersion in β Thalassaemia Major Patients
First Day Dynamic Changes in Antithrombin III Activity After Supplementation Have a Predictive Value in Critically III Patients
Elevated Fibrinogen Fragment Levels in Uremic Plasma Inhibit Platelet Function and Expression of Glycoprotein IIb-IIIa
Hospitalization Rates and Costs of Care of Patients With Sickle-Cell Anemia in the State of Maryland in the Era of Hydroxyurea
Inherited Thrombophilia is Associated With Deep Vein Thrombosis in a Colombian Population
NF-kB Inhibition as a Strategy to Enhance Etoposide-Induced Apoptosis in K562 Cell Line
Splenectomy in Plasma Cell Dyscrasias: A Review of the Clinical Practice
Waldenstrom’s Macroglobulinemia Presenting With Spinal Cord Compression: A Case Report
Role of Intra-arterial Steroid Administration in the Management of Steroid-Refractory Acute Gastrointestinal Graft-Versus-Host Disease
Concurrent Acute Myeloid Leukemia With inv(16)(p13.1q22) and Chronic Lymphocytic Leukemia: Molecular Evidence of Two Separate Diseases
Fatal Postlymphoma Chemotherapy Hepatitis B Reactivation Secondary to the Emergence of a YMDD Mutant Strain With Lamivudine Resistance in a Noncirrhotic Patient
High-Dose Therapy and Autologous Peripheral Blood Stem Cells Transplantation Followed by a Very Low Reduced Intensity Regimen With Fludarabine + Cyclophosphamide and Allograft Improve Complete Remission Rate in De Novo Multiple Myeloma Patients
Rituximab Monotherapy as Interim Therapy in Precursor B-ALL Adults During Periods of Hepatic Toxicity: Report of Two Cases
Histone Deacetylase Inhibitor FK228 is a Potent Inducer of Human Fetal Hemoglobin
Delayed Profound Thrombocytopenia Associated with Eptifibatide
Erythrocytosis Associated with Gestational Hyperandrogenism
A Family of Severe Congenital Neutropenia with -199C to A Substitution in ELA2 Promoter
A Long-Lasting Third Complete Remission after Second Autologous Transplant followed by Maintenance Treatment with Rituximab in a Patient with Diffuse Large Cell Non-Hodgkin's Lymphoma
VAD Combination Chemotherapy Followed by Bortezomib May Be an Effective Treatment in Secondary Plasma Cell Leukemia